Life Style

Remdesivir “has no meaningful effect” on COVID-19 survival, large study found

According to the results of a large international study, the antiviral drug remdesivir does not reduce mortality in COVID-19 patients compared to standard treatment.

The Food and Drug Administration will treat COVID-19 with remdesivir in an emergency in May after a large clinical trial suggests that COVID-19 patients will take less time to be discharged. I approved that. Compared to placebo treatment Live Science previously reported.. As of August, the drug has been approved for use in all patients admitted with COVID-19, not just those receiving oxygen supplementation. The New York Times reported.. Thousands of US patients, including the president, were treated.

Source link

Back to top button